PTPN2 inhibits pro-inflammatory pathways, including IFN-γ signaling, and mutations in PTPN2 are associated with chronic inflammatory and autoimmune diseases, including type I diabetes and Crohn’s disease (73). This evidence concerns the gene PTPN2 and type 1 diabetes mellitus.